{{.infobox .infobox-gene}}
| Symbol | KCNMB3 |
| Full Name | Potassium Calcium-Activated Channel Subfamily M Regulatory Beta Subunit 3 |
| Chromosome | 22q12.1 |
| NCBI Gene | 8912 |
| UniProt | Q9NS88 |
| Ensembl | ENSG00000143001 |
| Protein Length | 281 amino acids |
| Molecular Weight | ~31 kDa |
KCNMB3 encodes the beta 3 subunit (KCNMB3) of large-conductance calcium-activated potassium (BK) channels[1]. BK channels are widely expressed in various tissues including brain, smooth muscle, and endocrine cells, where they play crucial roles in regulating neuronal excitability, neurotransmitter release, and vascular tone[2]. The beta subunits modulate channel gating properties, trafficking, and pharmacological responses[3].
The BK channel (also known as Slo1 or KCa1.1) is a voltage-gated potassium channel with high conductance (100-200 pS) that is activated by both membrane depolarization and intracellular calcium[4]. The channel consists of four alpha subunits (encoded by KCNMA1) that form the pore, together with optional beta and gamma auxiliary subunits that modify channel properties.
KCNMB3 (beta 3) is one of four beta subunit isoforms (beta 1-4) that confer distinct properties to BK channels:
In neurons, BK channels regulate:
KCNMB3 is expressed in:
BK channel activation has been implicated in neuroprotection through several mechanisms:
Dysregulation of BK channel function is associated with:
While KCNMB3 is not a primary disease-causing gene, variations in BK channel complex genes have been linked to:
| Condition | Evidence | KCNMB3 Role |
|---|---|---|
| Epilepsy | Genetic association studies | Altered neuronal excitability |
| Migraine | GWAS signals near KCNMB3 locus | Vascular tone regulation |
| Cerebellar ataxia | Channel dysfunction | Impaired Purkinje cell function |
| Neuropathic pain | Peripheral nerve involvement | Sensory neuron hyperexcitability |
Given beta subunit expression in vascular smooth muscle:
Drugs targeting BK channels are under development for:
Several trials explore BK channel modulators for:
The KCNMB3 gene spans approximately 8 kb on chromosome 22q12.1 and contains:
| Partner | Interaction Type | Functional Effect |
|---|---|---|
| KCNMA1 | Channel assembly | Pore-forming subunit |
| KCNMB1 | Heteromerization | Beta subunit interactions |
| KCNMB2 | Co-assembly | Functional modulation |
| RGS proteins | Regulation | G-protein signaling |
KCNMB3: a calcium-activated potassium channel beta subunit. (2000). Proceedings of the National Academy of Sciences. 2000. ↩︎
BK channels in neuronal function. (2019). Physiological Reviews. 2019. ↩︎
Beta subunit modulation of BK channels. (2001). Journal of Biological Chemistry. 2001. ↩︎
Structure and function of BK channels. (2008). Annual Review of Physiology. 2008. ↩︎
Beta3 subunit specifically modulates BK channels. (2003). Journal of Neuroscience. 2003. ↩︎
BK channel pharmacology and beta subunits. (2012). Pharmacological Reviews. 2012. ↩︎
BK channels in synaptic transmission. (2015). Neuropharmacology. 2015. ↩︎
Regional distribution of BK channel beta subunits in brain. (2006). Brain Research. 2006. ↩︎
BK channel activation and neuroprotection. (2017). Cell Calcium. 2017. ↩︎
BK channel mutations in neurological disease. (2018). Brain. 2018. ↩︎
BK channels in cardiovascular disease. (2014). Cardiovascular Research. 2014. ↩︎
BK channel modulators in clinical development. (2020). Expert Opinion on Therapeutic Targets. 2020. ↩︎
Genetic variation in KCNMB3 and neurological traits. (2016). Human Molecular Genetics. 2016. ↩︎
Antibody validation for BK channel subunits. (2014). Journal of Immunological Methods. 2014. ↩︎